Takanori Morikawa
Papers
2
Total Citations
25
H-Index
2
About
Dr. Takanori Morikawa is a pioneering surgeon specializing in minimally invasive hepatobiliary surgery, with a particular focus on adult congenital biliary dilatation (CBD). His research has been instrumental in demonstrating the safety and efficacy of laparoscopic and robot-assisted techniques for this complex condition. Dr. Morikawa’s landmark 2022 study, with 14 citations, established that these advanced surgical approaches achieve favorable short-term outcomes—including reduced blood loss and shorter hospital stays—without increasing the risk of late complications such as cholangitis or anastomotic strictures. Earlier, his 2015 work on robotic surgery for type I CBD provided foundational evidence for the feasibility of robotic techniques in this rare disease, accumulating 11 citations. By systematically comparing minimally invasive approaches to traditional open surgery, Dr. Morikawa has helped shift clinical practice toward less invasive options, improving recovery and quality of life for patients. His contributions are particularly notable for addressing the unique challenges of adult CBD, where delayed diagnosis and prior interventions often complicate surgery. Dr. Morikawa’s work continues to influence guidelines and training in robotic hepatobiliary surgery, making him a key figure in advancing precision surgery for congenital bile duct disorders.
Research Focus
Key Achievements
Top Papers
- 1
- 2